Publications Office of the EU
Open house pharmaceutical discounts vitamins, combinations, ATC B05XC30 - EU tenders
DisplayCustomHeader
Procurement Detail Actions Portlet
OP Portal - Procurement - Details

This page contains content generated automatically to improve findability and accessibility

- indicates text translated automatically in your browsing language

Open house pharmaceutical discounts vitamins, combinations, ATC B05XC30

  • Published
    16/01/2024
  • Deadline
    05/01/2026
  • Opening of tenders
    05/01/2026
  • Today
    18/09/2026
Status
Submission closed
Type of contract
Supplies
Subject for Renewal
No
Buyer
AOK Bayern - Die Gesundheitskasse
Place of performance
NUTS code: Multiple place of performance
Location of buyer
NUTS code: DE212 München, Kreisfreie Stadt
Business sector (Main CPV)
33600000 Pharmaceutical products
Total estimated contract value (excluding VAT)
Not available
Total final contract value (excluding VAT)
Not available
Tender reference number
Not available
Description

It is not an open procedure but an open-house model! The open procedure form is used only because there is no open-house model form. In the absence of a selection decision, contracts concluded in the open-house model are not subject to public procurement law. The use of this form is not linked to the use of this form. AOK Bayern intends to conclude non-exclusive rebate agreements with all interested pharmaceutical companies concerning the combination of active ingredients vitamins, combinations, ATC B05XC30, pursuant to § 130a(8) SGB V. AOK Bayern offers to all interested pharmaceutical companies meeting the eligibility requirements set out below the conclusion of identical and non-individually negotiable discount agreements. The contract starts as soon as possible on 1 March 2024 and all contracts will end on 28 February 26. Contracts may be concluded at any time during this period, but not later than 5 January 2026. Contracts may be terminated by giving one month’s notice to the end of the month. On the entry into force of a national or Land-specific discount agreement for medicinal products with the active ingredient covered by the contract, concluded by open procedure, the open-house agreements shall automatically cease to apply for the corresponding duration. A contract is concluded with all interested pharmaceutical companies that demonstrate their suitability by means of a completed and signed self-declaration of reliability. The pharmaceutical company must submit the completed and signed contract (the signatory’s authorisation to represent the trade register, failing which a power of attorney must be provided) and a completed and signed annex ‘Determination of the medicinal products covered by the contract’ and the completed and signed self-declaration of reliability. The documents may be submitted in writing by hand OR ELECTRONICY with a qualified electronic signature. Hand-signed documents in writing must be sent in duplicate in the original to the following address: AOK Bayern – Health Insurance Agency SGB V ZE25 open-house discount agreements Carl-Wery-Str. 28 81739 Munich ELECTRONische Documents with a qualified electronic signature must be submitted via the communication section of the procurement portal www.dtvp.de. If complete and correct documents are received by the 5th of each month, the contract will start at the first of the following month and, failing that, the first day of the next month. In the case of manually signed documents in writing, the complete, completed and signed documents must be sent in advance by fax (089/62730650151), scanning to vergabestelle1@by.aok.de or via the communication section on the procurement portal www.dtvp.de, if the complete and correct original documents are received by AOK Bayern, contracting authority by 10th of the month. Please refer to the instructions for filling in the tender documents provided at www.dtvp.de Interested pharmaceutical companies can request the launch of the procurement documents in the open-house project room on the www.dtvp.de portal. A link to the portal is available in this notice. Only pharmaceutical companies can be considered as potential contractors. The documents relating to the open-house procedure shall be opened exclusively to pharmaceutical companies as potential contractors and shall be treated strictly confidentially. The request for activation by the companies confirms the confidentiality of the documents.

Submission Method
Electronic via:
https://www.dtvp.de/Satellite/notice/CXP4Y6YHMZU
Tenders may be submitted
Electronic submission: allowed
https://www.dtvp.de/Satellite/notice/CXP4Y6YHMZU
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
The procurement involves the establishment of a framework agreement
Conditions for opening tenders (date)
05/01/2026 12:01
Award method
Not available
Estimated value
Not available
Final contracted value
Not available
Award of contract
Not available
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.